With light, there is hope.
there is hope.
Surgery is a common treatment for ovarian cancer.
While your surgeon will use every tool at his or her disposal before and during surgery to assist in the removal of cancerous tissue, ovarian cancer can be difficult to visualize during surgery.
Now surgeons have a new technology in their corner – and yours. CYTALUX is the first FDA-approved fluorescent imaging technology to light up ovarian cancer in the operating room — enhancing your surgeon’s ability to see ovarian cancer in real-time during the procedure.
Put simply, CYTALUX™ helps enhance your surgeon’s ability to see ovarian cancer as they operate.
CYTALUX has been proven to help surgeons detect more ovarian cancer during surgery. In a clinical trial, CYTALUX was proven to help surgeons find and remove additional ovarian cancer that would have otherwise gone undetected in 27% of patients.
CYTALUX is given to patients intravenously 1-9 hours prior to surgery. It circulates through the body, binding to and “lighting up” ovarian cancer cells when used with a special surgical camera. This allows the surgeon to more easily see the tissue (via a surgical camera) as they operate. Errors may occur with the use of CYTALUX. Sometimes cells may light up even if they are not cancerous or those that are cancerous may not light up.
Adverse reactions consisting of nausea, vomiting, abdominal pain, flushing, indigestion, chest discomfort, and itching were reported during the administration of CYTALUX.
My doctor explained he would use a fluorescent dye and a special camera that would illuminate my cancer. There was one nodule that was hidden and he found it during the procedure.
-Carol, Ovarian Cancer Patient